L-Tryptophan Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about L-Tryptophan dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for L-Tryptophan.
Dosing Protocols
Beginner protocols — getting started with L-Tryptophan:
For mild sleep-onset difficulty (the classic beginner indication): L-Tryptophan 500mg orally, 30-60 minutes before bedtime, taken with a small carbohydrate snack (half a banana, a slice of whole-grain toast, a small bowl of rice — ~20g carbs, minimal protein). The carb snack is mechanistically important: insulin-driven BCAA uptake into muscle raises the tryptophan:LNAA ratio and delivers proportionally more tryptophan to brain. Expected timeline: subjective effects on sleep latency often noticed within 3-7 days; steady-state effects at 1-2 weeks. Track sleep onset time (subjective or via wearable) to honestly assess whether the supplement is doing anything.
For mild low mood or stress-related mood dip: L-Tryptophan 500mg-1g/day, either as a single evening dose or split AM/PM. With the PM dose, align with a small carb snack for best absorption. Expected timeline: 1-2 weeks for subjective mood effects. Combine with Vitamin B6 (P5P) 25mg/day and Magnesium glycinate 200-300mg elemental/day for cofactor support.
For mild irritability or PMS-related mood symptoms: L-Tryptophan 500mg-1g/day split AM/PM, with option to time PM dose with evening carb snack. For luteal-phase PMS use, some users dose only in the luteal phase (~14 days pre-menstrual) while others use continuously. Track symptoms with a simple daily journal.
Starting and titration: Most users tolerate 500mg from the start without issues. Begin at 500mg/day for 1 week, assess tolerance and initial effect. If well-tolerated and no clear effect, increase to 1g/day for 2 weeks. Re-assess. Further escalation to intermediate range (1-2g/day) only if needed.
Trial duration — honest self-assessment: Two weeks is a reasonable first trial for sleep-onset effects. For mood effects, 4 weeks is a better timeframe. If no meaningful benefit at 4 weeks at 1g/day with good lifestyle foundations, consider: (1) escalating to intermediate protocol; (2) switching to 5-HTP (which bypasses TPH rate-limit and may work where tryptophan doesn't); (3) discontinuing — tryptophan doesn't work for everyone.
Timing considerations: (1) Evening dosing is most common (sleep + mood overlap). (2) Empty stomach or with small carb snack (not with protein-rich meal). (3) AM dosing is less common and may cause daytime drowsiness; only suitable for users who don't find it sedating. (4) Consistent daily dosing is better than sporadic use for mood effects; for sleep, use as-needed dosing is also reasonable.
Monitoring: Track: (1) sleep onset latency, subjective sleep quality; (2) subjective mood, irritability, stress resilience (simple 1-10 daily scale); (3) any side effects (GI, drowsiness, vivid dreams, headache); (4) interactions — review all medications and supplements for serotonergic overlap (any SSRI, SNRI, MAOI, triptan, tramadol, dextromethorphan, 5-HTP, St. John's wort — stop or do not start tryptophan if on any of these without physician guidance).
Product quality — non-negotiable for beginners: Use USP-verified or third-party-tested L-tryptophan from established brands (Pure Encapsulations, NOW Foods with independent testing, Thorne, Life Extension, Jarrow, Double Wood). Avoid bulk tryptophan from unverified overseas sources — the 1989 EMS outbreak is not ancient history and contamination risk with poorly-sourced product is a real regulatory concern. Pay the extra $10-15/month for USP-verified product; it is genuinely worth it.
Lifestyle foundations: Tryptophan works best layered on sleep hygiene, regular aerobic exercise, morning sunlight exposure, adequate protein intake, and stress management. It is additive to these, not a substitute for them.
Duration: For sleep, continuous nightly use is reasonable if subjective benefit is present. For mood, 8-12 week trials with periodic reassessment work well — some users cycle (5 days on / 2 days off) to prevent habituation, though there is no formal evidence that tolerance develops at typical doses.
When to escalate: If 1g/day is well-tolerated and subjective benefits are modest, escalating to intermediate protocol (1-2g/day split) after 2-4 weeks is reasonable.
When to discontinue or switch: No meaningful benefit at 4-8 weeks, persistent side effects, or plan to start a serotonergic medication — discontinuation is appropriate. For inadequate effect at tryptophan, 5-HTP 50-100mg is the logical next step (bypasses the TPH rate-limit that may be preventing tryptophan response).
Intermediate protocols — therapeutic tryptophan dosing:
For moderate sleep-onset issues or mild chronic insomnia: L-Tryptophan 1-2g at bedtime, taken 30-60 minutes before sleep with a small carb snack. Add Magnesium glycinate 200-400mg elemental and Vitamin B6 (P5P) 50mg at bedtime for cofactor and synergistic GABAergic support. Expected timeline: 1-2 weeks for noticeable sleep-onset improvement at this dose. If ineffective at 2 weeks, consider whether chronic insomnia may warrant different interventions (CBT-I is first-line for chronic insomnia — tryptophan is adjunctive at best).
For mood support in healthy adults (Lindseth-style): L-Tryptophan 1-2g/day split AM and PM, with PM dose timed to evening carb snack. Add cofactor support: Vitamin B6 (P5P) 50mg/day, methylfolate 400-800mcg/day, methylcobalamin 500-1000mcg/day, Magnesium glycinate 300-400mg elemental/day. Continue for minimum 8 weeks before assessing efficacy. Expected effect size is modest — calibrate accordingly.
For aggression and irritability (Moskowitz 2001 protocol, adapted): L-Tryptophan 2-3g/day split. Moskowitz used 3g/day in the RCT; 2g/day split may be a reasonable starting point. Combine with L-Theanine 200-400mg/day for additional calming. This is tryptophan's best-supported non-sleep indication and is the specific intermediate use case where higher doses are evidence-supported.
For PMS/PMDD symptoms (Steinberg-style adapted): L-Tryptophan 2-4g/day during the luteal phase (roughly days 14-28 of menstrual cycle), or continuously at 1-2g/day. Steinberg's original work used 6g/day in the luteal phase for PMDD — this is the upper end and warrants physician awareness if used. Combine with calcium, vitamin D, magnesium, B6 as standard PMS supportive nutrients.
For stacked mood/sleep protocol — intermediate user: (1) Tryptophan 1g AM + 1g PM with carb snack (2g/day). (2) Vitamin B6 (P5P) 50mg AM. (3) Methylfolate 800mcg AM + methylcobalamin 1000mcg AM. (4) Magnesium glycinate 300mg elemental PM. (5) Omega-3 EPA/DHA 1.5-2g/day (EPA ≥60%). (6) Vitamin D 2000-5000 IU/day to target 25(OH)D 40-60 ng/mL. (7) L-Theanine 200mg AM as needed for daytime calm. Cycle assessment at 8-12 weeks — discontinue any component not demonstrating clear benefit.
Pulse dosing (5 on / 2 off): Some users adopt a 5 days on, 2 days off pattern to prevent habituation and give tryptophan-dependent enzyme systems a weekly reset. There is no formal evidence that tolerance develops at typical tryptophan doses (unlike SSRIs where receptor changes drive tolerance), but pulse dosing is low-risk and preferred by some experimenters. Continuous dosing is equally reasonable and simpler.
Tryptophan + low-dose endogenous melatonin support: Instead of taking exogenous melatonin, some users aim to raise endogenous melatonin via consistent nightly tryptophan. Protocol: Tryptophan 1-1.5g at bedtime with small carb snack, strict sleep hygiene (darkness, cool room, no screens 1h pre-bed). Endogenous melatonin rises more physiologically than exogenous bolus dosing. This is a preference call — exogenous low-dose melatonin (0.3-1mg) is also perfectly reasonable and has its own evidence base.
Adjusting dosing for body weight: Not typically weight-adjusted at standard doses. 1-2g/day works across adult body weights. For subjects <50kg, stay at lower end (1-1.5g/day). For subjects >100kg, 2g/day is reasonable. Exceeding 3g/day is not usually supported by improved efficacy.
Monitoring: (1) Baseline: document sleep quality, mood, irritability, stress level; review all medications for serotonergic overlap. (2) 4-week check: reassess same variables; track side effects; honest assessment of benefit vs placebo. (3) 8-12 week comprehensive reassessment: decide whether to continue at current dose, escalate to advanced protocol, or discontinue. (4) Ongoing: annual reassessment for long-term users; check in specifically about any new medications with serotonergic activity.
Stacking considerations at intermediate level: Combine tryptophan with one or two complementary mood/sleep supports initially (e.g., magnesium + B6 + omega-3) rather than building large stacks. Allows identification of which components are actually contributing. Avoid combining tryptophan with 5-HTP (redundant) or with SAM-e at high doses without cofactor awareness (methyl-group balance matters).
Cost-benefit evaluation at intermediate level: At 2g/day tryptophan from USP-verified product, monthly cost is typically $20-35 — cheaper than 5-HTP or SAM-e. Generally cost-effective if producing meaningful benefit. Not worth continuing at any price if benefit is not clearly present after a fair trial.
Medication considerations at intermediate level: At 2-3g/day, the serotonergic load is more substantial. Explicitly review and document all medications: SSRIs, SNRIs, MAOIs, triptans, tramadol, high-dose dextromethorphan, St. John's wort, lithium — any of these are reasons to stop or not start tryptophan, or to proceed only under physician guidance.
Advanced protocols and special contexts:
Maximum evidence-based tryptophan dose: 3-4g/day is the upper range used in most RCT protocols (Moskowitz 2001 used 3g/day for aggression; Steinberg et al. used 6g/day in luteal-phase PMDD — this is an outlier). Doses above 4g/day have been used in some research but are more likely to produce GI effects, drowsiness, vivid dreams, and morning grogginess without clearly improved efficacy. For most indications, there is no evidence basis for exceeding 4g/day.
Advanced PMS/PMDD (physician-directed): The Steinberg et al. 1999 protocol used 6g/day tryptophan during the luteal phase for PMDD — this is the upper bound and was physician-directed. Self-directed use at this dose is not recommended; if considering for severe PMDD, discuss with prescribing physician (OB/GYN or psychiatrist) alongside standard PMDD management (SSRIs are first-line; tryptophan is adjunctive).
Advanced treatment-resistant mild-moderate depression (physician-directed, non-first-line): Some integrative psychiatrists include tryptophan 2-4g/day split as part of a multimodal approach to treatment-resistant mild-moderate depression, alongside evidence-based antidepressants when indicated, omega-3, vitamin D optimization, methylated B-vitamins, SAM-e, and structured behavioral interventions (CBT, exercise prescription). Not a substitute for evidence-based antidepressants. Must be physician-directed because of interactions with prescription antidepressants — if on an SSRI, tryptophan is generally avoided; if the patient is antidepressant-free and the physician has specifically considered tryptophan, it may have a role as part of a broader plan.
Advanced chronic insomnia adjunct (adjunct to CBT-I): For chronic insomnia, first-line is cognitive behavioral therapy for insomnia (CBT-I) — tryptophan is adjunctive. Typical adjunctive protocol: Tryptophan 2-3g at bedtime with carb snack, plus Magnesium glycinate, glycine 3g, and strict sleep hygiene. Evidence for tryptophan in chronic insomnia at these doses is limited; CBT-I remains the evidence-based core intervention.
Advanced aggression/irritability (Moskowitz-style): Moskowitz 2001used 3g/day tryptophan and found reduced quarrelsomeness over 12 days. This is the best-supported tryptophan indication at higher doses. Physician awareness is reasonable for prolonged use at this dose, but the protocol itself is well-tolerated.
Tryptophan in substance-use contexts: Tryptophan has been studied as an adjunct in alcohol withdrawal, stimulant withdrawal, and as a harm-reduction supplement in MDMA-use contexts (the idea being that MDMA depletes serotonin and tryptophan may aid recovery). These are not evidence-established applications; caution is warranted because any concurrent serotonergic drug use is a contraindication. Do not combine tryptophan with active MDMA use — tryptophan several days before or after MDMA has been discussed in harm-reduction communities, but formal evidence is absent, serotonin syndrome risk with concurrent use is real, and this is not medical advice.
Tryptophan and pain contexts — caution: Some chronic pain patients are prescribed tramadol (serotonergic analgesic) or are on SSRIs/SNRIs for chronic pain. Tryptophan is contraindicated in these contexts unless the physician has specifically considered and approved it. Alternative non-serotonergic approaches (magnesium, omega-3, vitamin D, lifestyle interventions) are better choices.
Tryptophan and high-protein / low-carb diets: Users on ketogenic or very high-protein diets face a mechanistic headwind for tryptophan supplementation — the constant elevation of competing LNAAs blunts brain uptake. Mitigations: (1) take tryptophan at least 2 hours away from protein meals; (2) allow a brief low-protein window (fasting or a small carb snack); (3) consider 5-HTP as an alternative since it bypasses the LNAA-competition problem (5-HTP uses different transport mechanisms).
Tryptophan + exercise timing: Exercise lowers plasma BCAAs via muscle uptake, transiently raising the tryptophan:LNAA ratio. Post-exercise tryptophan dosing may have enhanced brain uptake. Not a major clinical lever, but a mechanistic consideration for experimenters optimizing protocols.
Long-term users — clinical monitoring: (1) Baseline labs: CBC with differential (specifically eosinophil count — this is a legacy of the EMS history; not currently required but not unreasonable in long-term users), liver enzymes, comprehensive metabolic panel, 25(OH)D, B12, folate. Baseline mood and sleep self-rating. (2) Annual reassessment: CBC, liver enzymes, clinical status, review of continued benefit, review of medications for emerging serotonergic interactions. (3) Specific life transitions: any new medication warrants a drug-interaction check (SSRIs, SNRIs, MAOIs, triptans, tramadol, dextromethorphan, St. John's wort are the main concerns); pregnancy warrants discontinuation and obstetrician guidance; new eosinophilia or myalgia warrants evaluation and discontinuation pending workup.
Product quality at advanced use: For chronic long-term use at 2-4g/day, product quality is critical. Prefer: (1) USP-verified products — this is the single most important criterion given the EMS legacy; (2) Third-party tested (NSF, USP, or independent lab with published COA); (3) Established brands (Pure Encapsulations, NOW Foods, Thorne, Life Extension, Jarrow, Double Wood); (4) Ajinomoto-sourced tryptophan when specified on the label — Ajinomoto is a large, well-regulated Japanese amino acid manufacturer with a reputation for purity. Avoid: generic "tryptophan" from unverified overseas bulk sources at suspiciously low prices — the quality variance is real and EMS-like contamination, while rare, is not impossible with poorly-sourced product.
Research directions and emerging applications: Active research includes the kynurenine pathway in depression and neuroinflammation (KMO inhibitors are under investigation as novel antidepressants), gut microbiome tryptophan metabolism (indole derivatives produced by gut bacteria act on host AhR signaling and modulate gut-brain axis), tryptophan in circadian regulation, and tryptophan's role in specific neurological conditions. These are research-stage and not currently established clinical indications.
Honest framing at the advanced level: After months-to-years of tryptophan use at therapeutic doses, honest users often describe subtle benefits — mildly better sleep, perhaps slightly improved mood and stress resilience — that are layered on top of lifestyle optimization and that are hard to distinguish from placebo or from concurrent factors. The more expansive claims (tryptophan as an antidepressant substitute, dramatic cognitive enhancement, curing insomnia) are not supported by the evidence. Set expectations accordingly. If after 8-12 weeks at adequate dose with good lifestyle foundations you see no meaningful benefit, discontinuation is reasonable — tryptophan is not a compound for persistent long-term use in the absence of benefit.
Commonly Stacked With
L-Tryptophan stacks thoughtfully with several cofactor and adjunct compounds, but because of its serotonergic activity it also has several absolute no-combine interactions that must be respected.
Cofactor stack — supporting TPH and AADC efficiency: Tryptophan's conversion to serotonin requires tetrahydrobiopterin (BH4), iron, oxygen (TPH), and pyridoxal-5-phosphate (active B6) (AADC). Co-supplementing these cofactors in the right range is a reasonable adjunct:
- Vitamin B6 (pyridoxal-5-phosphate or P5P) 25-50mg/day — active B6 is the cofactor for AADC conversion of 5-HTP to serotonin. Low B6 status is associated with impaired serotonin synthesis. Don't exceed ~100mg/day of chronic B6 due to peripheral neuropathy risk at very high chronic doses.
- Magnesium glycinate 200-400mg elemental/day — cofactor for many enzymatic steps, mild GABAergic support, improves sleep quality which complements tryptophan's sleep effect.
- Zinc 15-30mg/day (with 1-2mg copper) — cofactor for several neurotransmitter-synthesis enzymes; generally supportive.
- Iron — only if ferritin is low (check labs). TPH requires iron, and low ferritin has been associated with depression and sleep disturbance. Don't supplement iron without confirmed deficiency — iron excess has its own risks.
- Folate and B12 (methylated forms) — cofactors for BH4 regeneration via the methylation cycle. Methylfolate 400-800mcg and methylcobalamin 500-1000mcg daily are reasonable for most users.
Carbohydrate timing — the mechanistic amplifier: Because tryptophan's brain uptake depends on the tryptophan:LNAA ratio at the BBB, and insulin release shunts BCAAs into muscle, a small carbohydrate snack (~20-30g carbs, minimal protein) taken with tryptophan raises brain tryptophan delivery substantially. Options: a slice of whole-grain toast with a teaspoon of honey or jam, half a banana, a small bowl of rice, a handful of pretzels. Avoid high-protein snacks (peanut butter, cheese, yogurt, meat) which defeat the mechanism. If the goal is a pure amino acid competition advantage, empty stomach may even be preferable to a protein-containing snack.
For sleep — pairing with other sleep-supportive compounds:
- Tryptophan 500mg-2g at bedtime + Magnesium glycinate 200-400mg elemental — classic combination, magnesium supports GABA-A signaling while tryptophan supports serotonin/melatonin.
- Glycine 3g at bedtime — additional sleep support via NMDA co-agonist activity and core temperature regulation.
- Low-dose melatonin 0.3-1mg — direct circadian support; the combination is reasonable when endogenous melatonin production may be inadequate (shift work, jet lag, older adults).
- L-Theanine 200mg — calming without sedation; pairs well for anxiety-associated sleep onset.
- Apigenin 50mg — mild GABAergic.
For mood support — stacking with complementary compounds:
- Tryptophan 1-2g/day split AM/PM + B6 + magnesium — the cofactor-supported baseline.
- SAM-e 200-400mg/day — methyl donor supportive of monoamine neurotransmitter synthesis generally; has independent antidepressant evidence.
- Omega-3 EPA/DHA 1-2g/day with EPA ≥60% — modest antidepressant evidence, complementary mechanism.
- Vitamin D to 25(OH)D 40-60 ng/mL — foundational; low vitamin D is associated with depression.
- Rhodiola 200-400mg standardized extract/day — adaptogen with mild mood/energy support; complements serotonergic approach.
- Lithium Orotate 5-10mg elemental lithium/day — low-dose lithium may have mood-stabilizing effects; evidence is limited but reasonable in self-experimentation context (not a substitute for therapeutic lithium in bipolar disorder).
For aggression/irritability — the RCT-supported use:
- Tryptophan 1-3g/day split (Moskowitz 2001 used 3g/day) — the best-supported tryptophan indication beyond sleep.
- L-Theanine 200-400mg/day — additional calming.
- Ashwagandha 300-600mg standardized extract/day — adaptogen with stress-reduction evidence.
- Magnesium glycinate 300-400mg elemental — foundational.
Tryptophan vs 5-HTP — choosing when: A common question. Both eventually produce serotonin, but they differ in:
- 5-HTP bypasses TPH (rate-limiting) — faster, more potent, more direct serotonergic effect at lower doses; but more room to overshoot (serotonin syndrome risk with interacting drugs is somewhat higher), and less subject to endogenous feedback regulation.
- Tryptophan respects TPH rate-limit — gentler, slower, subject to homeostatic feedback; higher doses needed for equivalent effect; safer profile when combining with mild serotonergic agents (still avoid all major ones).
Practical rule: start with tryptophan unless there's a specific reason to prefer 5-HTP (usually faster onset or tighter dose control). Avoid using both simultaneously — redundant and additive without mechanistic benefit.
Avoid or absolute no-combine:
- SSRIs, SNRIs, MAOIs, linezolid, methylene blue, St. John's wort — serotonin syndrome risk.
- Triptans (migraine), tramadol, high-dose dextromethorphan, MDMA, cocaine — serotonergic; risk of syndrome.
- 5-HTP — redundant.
- Lithium (prescription doses) — discuss with prescriber; may increase serotonin syndrome risk.
Non-supplement foundation: Tryptophan's effects are additive to — and often less impactful than — foundational lifestyle factors: (1) sleep hygiene (dark, cool, consistent bedtime, avoid screens 1h before bed); (2) regular aerobic exercise (acutely raises tryptophan:LNAA via muscle BCAA uptake, and has strong independent antidepressant/anxiolytic evidence); (3) sunlight exposure (morning sunlight synchronizes circadian rhythm and supports endogenous serotonin/melatonin); (4) adequate protein intake (dietary tryptophan baseline matters); (5) stress management (chronic stress upregulates hepatic TDO, shunting tryptophan into the kynurenine pathway and away from serotonin — this is a real mechanism linking chronic stress to low-mood physiology).
Side Effects & Safety
Contraindications
**Absolute contraindications**: **Known hypersensitivity** to L-tryptophan, product excipients, or prior allergic reaction — discontinue if rash, swelling, or other allergic symptoms occur. **Concurrent MAOI use** (phenelzine, tranylcypromine, selegiline, rasagiline, **linezolid** — an antibiotic with weak but clinically relevant MAOI activity, **methylene blue** — another accidental MAOI) — **absolute contraindication**. MAOIs prevent serotonin breakdown; adding tryptophan amplifies synthesis and substantially raises serotonin syndrome risk. This combination is among the most dangerous in psychiatry and must be avoided. Washout periods from MAOI discontinuation are typically **2 weeks** before initiating tryptophan. **Concurrent SSRI, SNRI, or other serotonergic antidepressant use** (sertraline, fluoxetine, paroxetine, citalopram, escitalopram, venlafaxine, duloxetine, etc.) — **generally avoided** due to serotonin syndrome risk. If switching from SSRI to tryptophan, allow **at least 2 weeks washout** for most SSRIs, **5-6 weeks for fluoxetine** (due to its long half-life). **Carcinoid syndrome** — a rare tumor-related condition in which neuroendocrine tumors produce excess serotonin. Tryptophan supplementation provides additional substrate for tumor serotonin synthesis and can exacerbate symptoms. **Absolute contraindication**. **Active pregnancy** — tryptophan supplementation is not routinely recommended in pregnancy. Theoretical concerns about fetal serotonergic effects (serotonin signaling is important in fetal brain development and pharmacologic modulation during pregnancy is poorly characterized for tryptophan) argue for avoiding supplements and relying on dietary tryptophan from protein foods. Not an absolute contraindication in the sense of "unsafe at any dose," but strongly preferred to avoid. **Relative contraindications requiring medical guidance**: **Severe hepatic dysfunction** — TDO is the main hepatic tryptophan 2,3-dioxygenase; advanced liver disease can alter tryptophan metabolism and kynurenine-pathway flux. Not an absolute contraindication but warrants physician input and may warrant lower doses. **Severe renal impairment (eGFR <30)** — kynurenine metabolites are partly renally cleared; accumulation of metabolites may occur with severely impaired clearance. Physician input is reasonable for long-term supplementation in advanced CKD. **Concurrent triptan use** (sumatriptan, rizatriptan, eletriptan, almotriptan, naratriptan, frovatriptan, zolmitriptan — migraine abortive medications) — serotonergic activity overlaps; avoid routine daily tryptophan in users who take triptans frequently. Occasional triptan use with daily tryptophan requires awareness of serotonin syndrome risk, though reports of syndrome from this combination are rare. **Concurrent tramadol** — tramadol has serotonergic activity (it is a weak SNRI in addition to being a weak mu-opioid agonist); concurrent daily tryptophan is generally avoided. **Concurrent high-dose dextromethorphan** — DXM is serotonergic at high doses (as in recreational use or high-dose cough suppressant); concurrent tryptophan is a risk factor for serotonin syndrome. **Concurrent [5-HTP](/compound/5-htp) use** — redundant (5-HTP is already one metabolic step downstream of tryptophan) and additive without mechanistic benefit. Avoid combining. **Concurrent St. John's wort** — has SSRI-like serotonergic activity. Avoid combining. **Concurrent lithium** — not directly serotonergic but associated with serotonin syndrome cases when combined with other serotonergic agents. Discuss with prescribing physician before combining therapeutic-dose lithium with supplemental tryptophan. **Concurrent MDMA or other serotonergic recreational drugs** — **absolute avoid**. Serotonin syndrome risk is real and can be severe. **Bipolar disorder** — tryptophan can theoretically destabilize mood in bipolar patients (any serotonergic agent has this theoretical risk). Not an absolute contraindication but warrants psychiatrist input and close monitoring for hypomanic/manic switching. **Current or recent eosinophilic illness** — the 1989 EMS legacy means that any concurrent eosinophilic condition (eosinophilic esophagitis, Churg-Strauss syndrome, eosinophilic fasciitis) warrants avoiding tryptophan pending hematology/immunology workup. **Pregnancy-specific considerations**: As above, not an absolute contraindication but strongly preferred to avoid supplementation during pregnancy. Dietary tryptophan from protein foods is fine and represents normal nutritional practice. If tryptophan is being considered during pregnancy for severe clinical indication, this is a physician-level decision. **Breastfeeding**: Tryptophan is present in breast milk normally; supplemental dosing has limited specific safety data. Not recommended without obstetrician/pediatrician input. **Pediatric use**: **Not recommended under 18 years** — insufficient safety and efficacy data for children and adolescents. Pediatric serotonergic supplementation, when clinically appropriate, is done with specialist guidance and typically uses alternative approaches. **Situations warranting medical consultation before use**: - **Any psychiatric medication use** — particularly SSRIs, SNRIs, MAOIs, lithium, buspirone, trazodone, mirtazapine. - **Migraine with triptan use** — timing and frequency coordination. - **Chronic pain on tramadol** — alternative non-serotonergic approaches preferred. - **Bipolar disorder** — psychiatrist input. - **Pregnancy or planning pregnancy** — default to dietary tryptophan. - **Severe liver or kidney disease** — physician input on dose and appropriateness. - **Active eosinophilic or autoimmune illness** — workup before supplementation. - **Surgery planned** — generally no specific tryptophan concern with routine anesthesia, but inform surgical team of all supplements. **New neurological or autonomic symptoms on tryptophan** — mental status changes, unusual tremor or clonus, autonomic signs (tachycardia, hyperthermia, diaphoresis), severe GI symptoms, muscle pain, or eosinophilia-like presentation warrant evaluation and discontinuation pending workup. Serotonin syndrome is the acute concern with concurrent serotonergic drug use; EMS-like reactions are historically rare with quality-sourced product but remain part of the legacy consideration. **Legal and regulatory status**: L-Tryptophan is a **dietary supplement** in the US (since the early 2000s when the FDA import alert was relaxed following improvements in manufacturing and testing), Canada, UK, EU, Australia, and most countries — legally available without prescription. Not a controlled substance; not restricted in competitive sport (WADA permits amino acid supplementation). Products should comply with dietary supplement GMP and labeling requirements, and USP verification is strongly preferred given the EMS history. **Quality variability concern**: As discussed in reconstitution notes, the 1989 EMS outbreak resulted from contaminants in a specific Showa Denko bulk product, not from tryptophan itself. Current USP-verified products are extensively tested and have an excellent safety record. Generic tryptophan from unverified overseas bulk sources carries real (if small) quality-variance risk. Prefer USP-verified product for any chronic or higher-dose use. **Not medical advice**: This content is educational. Specific use decisions — particularly in psychiatric medication contexts, pregnancy, liver or kidney disease, or with any serotonergic drug interaction — warrant physician-level guidance tailored to individual circumstances. Research compound — not a substitute for evidence-based medical care.
Additional Notes
Dosing by indication:
Mild sleep-onset difficulty: 500mg-1g at bedtime with small carb snack, 30-60 minutes before sleep.
Moderate sleep issues: 1-2g at bedtime with carb snack.
Mild mood support (healthy adults): 500mg-1g/day, single evening dose or split AM/PM.
Moderate mood support: 1-2g/day split AM/PM, PM dose with carb snack.
Aggression/irritability (Moskowitz protocol): 2-3g/day split over 12+ days.
PMS symptoms: 1-2g/day continuous or 2-4g/day during luteal phase.
PMDD (advanced, physician-directed): up to 6g/day during luteal phase (Steinberg protocol) — not for self-directed use at this dose.
Beginner / tolerance assessment: 500mg/day for 1-2 weeks before escalating.
Maximum commonly used: 3-4g/day; doses above 4g are not typically better and increase side effect likelihood.
Dosage forms: (1) Capsules — typical L-tryptophan capsules are 500mg each, so 1-2g/day requires 2-4 capsules. Most common form. (2) Powder — bulk L-tryptophan powder (Ajinomoto-sourced preferred) for precise dosing or high-dose use. Powder can be mixed in water, juice, or stirred into a small amount of honey. Has a mildly sweet-bitter taste. (3) Food-based — dietary protein (turkey, chicken, eggs, cheese, fish, pumpkin seeds, soybeans, oats) provides 0.5-1.5g tryptophan per meal depending on portion; dietary approach is well-supported for general nutrition but does not produce the same pharmacologic effect as supplemental tryptophan due to LNAA competition.
Timing considerations: (1) Evening dosing is most common (sleep + mood overlap). For mood-only use, evening dosing is still often preferred to capture the downstream melatonin-pathway sleep benefit. (2) AM dosing may cause drowsiness; suitable only if no sedation occurs. (3) With carb snack (~20-30g carbs, minimal protein) — mechanistically important for brain uptake; the difference between empty stomach and small carb snack is often noticeable. (4) Avoid with high-protein meals — LNAA competition blunts brain uptake substantially. (5) Missed doses: skip and resume next scheduled dose; do not double up.
Pharmacokinetics summary: Oral bioavailability is high (~80-90%). Peak plasma tryptophan ~1-2 hours post-dose. Half-life is short (~1-3 hours in circulation), but pharmacodynamic effects (via serotonin/melatonin synthesis) outlast plasma levels. TPH rate-limiting means dose-response is non-linear — doubling the dose does not double the serotonergic effect; higher doses have diminishing returns. Clearance is primarily hepatic (TDO) with kidney contribution for some metabolites.
Onset: Acute effects (sleep latency, mild sedation) often noticed within 30-90 minutes. Subjective mood effects typically require 1-2 weeks of consistent dosing. Peak effect on mood outcomes at 4-8 weeks in most protocols.
Dose adjustment for body weight: Not typically weight-adjusted at standard doses. 1-2g/day works across adult body weights; adjust at extremes (<50kg stay lower, >100kg may use 2g/day).
Adjustments for renal impairment: Tryptophan clearance is primarily hepatic; standard dosing is generally safe in mild-moderate renal impairment. In severe renal impairment (eGFR <30), physician input is reasonable — kynurenine metabolites are partly renally cleared and may accumulate.
Adjustments for hepatic impairment: Severe hepatic dysfunction reduces TDO activity and may alter kynurenine-pathway metabolism. Standard dosing is generally fine for mild-moderate liver disease; severe liver disease warrants physician input.
Escalation/de-escalation: Standard escalation: 500mg/day for 1-2 weeks → 1g/day for 2 weeks → 1.5-2g/day if needed. De-escalation: no taper needed; can discontinue abruptly without rebound. Some users note mild short-term sleep disruption in the first 2-3 nights after stopping evening dosing — this usually self-resolves.
Concurrent medication considerations: Review all medications for serotonergic activity before starting tryptophan. Common interactions: SSRIs (sertraline, fluoxetine, paroxetine, citalopram, escitalopram), SNRIs (venlafaxine, duloxetine), MAOIs (phenelzine, tranylcypromine, selegiline, rasagiline, linezolid, methylene blue), triptans (sumatriptan, rizatriptan, etc.), tramadol, high-dose dextromethorphan, 5-HTP, St. John's wort, lithium. If on any of these, tryptophan is generally avoided or requires physician guidance.
Lab considerations: No routine labs required for standard use in healthy adults. For long-term users or at higher doses, consider baseline CBC (eosinophil count — legacy consideration from EMS), liver enzymes, CMP, 25(OH)D, B12, folate annually. Serum tryptophan levels are not commonly used clinically and have limited utility for dose-titration decisions.
Cost: USP-verified L-tryptophan typically costs $15-30/month at 1-2g/day from mid-market brands. Bulk Ajinomoto-sourced powder is more cost-effective for chronic higher-dose use ($10-20/month equivalent). Generally one of the more cost-effective mood/sleep supplements.
Frequently Asked Questions
What is the recommended L-Tryptophan dosage?
Dosage for L-Tryptophan varies by protocol. Consult a qualified healthcare provider.
How often should I take L-Tryptophan?
Administration frequency depends on the specific protocol. Consult current research literature.
Does L-Tryptophan need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are L-Tryptophan side effects?
**L-Tryptophan has a generally favorable side effect profile at standard doses** in quality-sourced product, but several considerations — particularly serotonin syndrome risk and the 1989 EMS legacy — warrant specific attention. **Gastrointestinal effects — the most common issue**: At typical doses (500mg-3g/day), ~5-10% of users report **mild nausea**, **stomach discomfort**, **bloating**, or occasional loose stools. These are more common at higher doses and when tryptophan is taken on an empty stomach. Mitigations: divide the dose, take with a small carbohydrate snack (which also improves brain uptake), titrate gradually from 500mg/day. Persistent severe GI effects warrant discontinuation and evaluation. **Drowsiness and daytime sedation**: Tryptophan's downstream serotonin → melatonin pathway produces mild sedation in many users, which is typically the desired effect when taken at bedtime but can be problematic with daytime dosing. Many users report feeling "slowed down," mentally cloudy, or sleepy with AM dosing. Shifting the dose to evening usually resolves this. Driving or operating machinery should be approached cautiously during initial dosing. **Vivid dreams and sleep architecture changes**: A minority of users report **unusually vivid dreams**, **lucid dreams**, or occasional nightmares, particularly at doses ≥2g. This reflects tryptophan's effect on serotonergic/melatonergic regulation of REM sleep. Usually benign; if dreams become distressing, reduce dose. **Morning grogginess at high doses**: At doses ≥3g, some users report residual morning grogginess — analogous to the "hangover" from high-dose sleep medications, though typically milder. Dose reduction resolves this. **Headache**: Uncommon but reported, particularly at higher doses or in users sensitive to serotonergic agents. Dose-responsive. **Paradoxical anxiety or agitation**: A minority of users — perhaps those with pre-existing serotonin sensitivity or underlying anxiety disorders — report increased anxiety, jitteriness, or agitation on tryptophan. This may reflect individual variation in 5-HT receptor sensitivity (particularly 5-HT2A/2C activation, which can be anxiogenic). Discontinuation resolves; not a reason to push through. **Serotonin syndrome — the central safety concern with interacting drugs**: Serotonin syndrome is a potentially life-threatening hyperserotonergic state characterized by mental status changes (agitation, confusion, hallucinations), autonomic hyperactivity (tachycardia, hypertension, hyperthermia, diaphoresis, flushing), and neuromuscular hyperactivity (tremor, clonus, hyperreflexia, rigidity). **Tryptophan alone rarely causes serotonin syndrome** — the TPH rate-limit and endogenous feedback regulation are protective — but **tryptophan combined with other serotonergic agents can precipitate it**. High-risk combinations (avoid or use only under physician supervision with explicit awareness of the risk): - **SSRIs** (sertraline, fluoxetine, paroxetine, citalopram, escitalopram) — avoid combining with supplemental tryptophan. If switching from SSRI to tryptophan, allow **at least 2 weeks washout** for most SSRIs, **5-6 weeks for fluoxetine** (due to its long half-life). - **MAOIs** (phenelzine, tranylcypromine, selegiline, rasagiline, **linezolid** — an antibiotic with weak MAOI activity, **methylene blue** — another accidental MAOI) — absolute avoid. MAOIs prevent serotonin breakdown; adding tryptophan amplifies synthesis. This combination is among the most dangerous in psychiatry. - **SNRIs** (venlafaxine, duloxetine) — avoid. - **Triptans** (sumatriptan, rizatriptan, etc., for migraine) — caution; concurrent daily tryptophan use is generally avoided. - **Tramadol** — has serotonergic activity; avoid combining. - **Dextromethorphan (high-dose, as in cough suppressants used recreationally or for cough)** — serotonergic; caution with concurrent tryptophan. - **MDMA, cocaine, other serotonergic recreational drugs** — absolute avoid. - **[5-HTP](/compound/5-htp)** — redundant and additive; avoid combining tryptophan and 5-HTP. - **St. John's wort** — has SSRI-like serotonergic activity; avoid combining. - **Lithium** — not directly serotonergic but has been associated with serotonin syndrome cases when combined with other serotonergic agents; discuss with prescriber. Symptoms of serotonin syndrome are typically acute (hours to a day after starting the combination or escalating dose) and warrant **emergency evaluation**. Severe cases require ICU-level care. Most cases resolve within 24-72 hours with discontinuation of serotonergic agents and supportive care. **Eosinophilia-myalgia syndrome (EMS) legacy — 1989 and why third-party testing matters**: As noted elsewhere, the 1989 EMS outbreak associated with Showa Denko-sourced tryptophan (~1,500 cases, ~37 deaths) was traced to specific contaminants ("peak E" / EBT — 1,1'-ethylidenebis[tryptophan] — plus related impurities) from a modified fermentation process. Tryptophan itself was not the causative agent. Current USP-verified products are extensively tested for these contaminants. **Practical implication**: prefer products with explicit USP verification, third-party testing certificates (NSF, USP, or independent lab verification with published COAs), and established supplement brands with quality reputations (Pure Encapsulations, NOW Foods, Thorne, Jarrow, Life Extension, Ajinomoto-sourced, Double Wood). Avoid bulk tryptophan from unverified overseas sources — the quality variance is real and the EMS history is not ancient history for regulators. **Pregnancy and lactation**: Supplemental tryptophan is **not routinely recommended in pregnancy** — theoretical concerns about fetal serotonergic effects (serotonin signaling is important in fetal brain development, and pharmacologic modulation during pregnancy is poorly characterized for tryptophan) argue for defaulting to dietary tryptophan (from protein foods) rather than supplements. Lactation: tryptophan is present in breast milk normally; supplemental dosing has limited safety data. Discuss with obstetrician/pediatrician before use. **Pediatric use**: Not recommended under 18 without specific pediatric clinical indication and pediatrician guidance. No safety signals specifically with tryptophan in pediatrics beyond adult considerations, but dose, indication, and drug-interaction profiles differ in children and adolescents. **Pre-existing liver disease**: Severe hepatic dysfunction reduces TDO activity (TDO is the liver's main tryptophan 2,3-dioxygenase) and may alter kynurenine-pathway flux. Rarely a clinically meaningful concern for typical supplemental use but warrants physician input in advanced liver disease. **Carcinoid syndrome**: A rare tumor-related condition in which neuroendocrine tumors produce excess serotonin. Tryptophan supplementation is **contraindicated** in carcinoid syndrome — it provides additional substrate for tumor serotonin synthesis and can exacerbate symptoms. **Expected vs concerning symptoms**: Expected: mild initial GI adjustment, evening drowsiness, vivid dreams, subtle mood effects over 1-2 weeks. Concerning: mental status changes (confusion, agitation, hallucinations), autonomic signs (tachycardia, hyperthermia, diaphoresis), neuromuscular signs (tremor, clonus, hyperreflexia) — these may indicate serotonin syndrome and warrant immediate evaluation; persistent severe GI effects; muscle pain or eosinophilia (evaluate for EMS-like reactions, exceptionally rare with quality-sourced product); any allergic reaction.
Where can I buy L-Tryptophan?
Visit our vendor directory to find trusted sources for L-Tryptophan.
L-Tryptophan Full Profile
Research data, mechanisms, and pricing
Interaction Checker
Check drug & compound interactions
Related Dosage Guides
All GuidesFree 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
